FDA Inspection
The Tender CorporationThe Tender Corporation – FDA Inspection, Nov 25, 2019
Record Details
This FDA Inspection record concerns The Tender Corporation, with an inspection on November 25, 2019, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- The Tender Corporation
- Inspection Date
- November 25, 2019
- Product Type
- Drugs
View Company Profile
ID · dc11cc28-1352-438e-a154-5a01e7b5ae89
Inspection Facts
Official Action Indicated (OAI)
Significant objectionable conditions were found and regulatory or administrative action is recommended.
- Inspection number
- 1110927
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Enforcement
- Warning Letter
FDA Citations
6- 21 CFR 211.188Prepared for each batch, include complete information
- 21 CFR 211.160(a)Following/documenting laboratory controls
- 21 CFR 211.160(b)Scientifically sound laboratory controls
- 21 CFR 211.194(a)(4)Complete Test Data
- 21 CFR 211.192Investigations of discrepancies, failures
- 21 CFR 211.22(d)Procedures not in writing, fully followed
Full citation text and observation details available on the Dashboard.
Other FDA inspections of The Tender Corporation
8| Date | Classification | Office | Project area |
|---|---|---|---|
| April 10, 2026 | Not classified | New England District Office | Drug Quality Assurance |
| April 26, 2023 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 23, 2021 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| October 26, 2018 | VAI | Center for Devices and Radiological Health | Compliance: Devices |
| June 7, 2018 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for The Tender Corporation
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.